Autoimmune hepatitis: Single-center experience of clinical presentation, response to treatment and prognosis in Saudi Arabia

Saudi Journal of Gastroenterology

Volumn 16, Issue 2, 2010, Pages 95-99

  Fallatah, Hind I ^a   Akbar, Hisham O ^a   Qari, Yousif A ^a  

^a KING ABDUL AZIZ UNIVERSITY HOSPITAL   (Saudi Arabia)

Author keywords

Autoimmune hepatitis; Clinical presentation; Laboratory features; Saudi Arabia; Treatment

Indexed keywords

AZATHIOPRINE; BILIRUBIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE;

ADULT; ARTICLE; AUTOIMMUNE HEPATITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG WITHDRAWAL; ESOPHAGUS VARICES; FEMALE; GASTROINTESTINAL ENDOSCOPY; HASHIMOTO DISEASE; HUMAN; HYPERSPLENISM; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FUNCTION TEST; MALE; PANCYTOPENIA; PROGNOSIS; RELAPSE; RHEUMATOID ARTHRITIS; SAUDI ARABIA; SYSTEMIC LUPUS ERYTHEMATOSUS; UNSPECIFIED SIDE EFFECT;

ADOLESCENT; ADULT; AGED; AZATHIOPRINE; BLOOD CHEMICAL ANALYSIS; CHI-SQUARE DISTRIBUTION; CHILD; COHORT STUDIES; DISEASE PROGRESSION; DRUG THERAPY, COMBINATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HEPATITIS, AUTOIMMUNE; HOSPITALS, UNIVERSITY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; PREDNISOLONE; PROBABILITY; RECURRENCE; RISK ASSESSMENT; SAUDI ARABIA; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; YOUNG ADULT;

EID: 77950544383     PISSN: 13193767     EISSN: 19984049     Source Type: Journal    
DOI: 10.4103/1319-3767.61235     Document Type: Article

References (24)

1. Czaja AJ. Diagnosis and therapy of autoimmune liver disease. Med Clin North Am 1996;80:973-994
2. Floreani A, Niro G, Rosa Rizzotto E, Antoniazzi S, Ferrara F, Carderi I, et al. Type I autoimmune hepatitis: clinical course and outcome in an Italian multicentre study. Aliment Pharmacol Ther 2006;24:1051-1057
3. Bellomo-Brandão MA, Costa-Pinto EA, de Tommaso AM, Hessel G. Clinical and biochemical features of autoimmune hepatitis in 36 pediatric patients. Arq Gastroenterol 2006;43:45-49
4. Miyake Y, Iwasaki Y, Takaki A, Kobashi H, Sakaguchi K, Shiratori Y. Clinical features of Japanese elderly patients with type 1 autoimmune hepatitis. Intern Med 2007;46:1945-1949
5. Czaja AJ, Carpenter HA. Distinctive clinical phenotype and treatment outcome of type 1 autoimmune hepatitis in the elderly, Hepatology 2006;43:532-538
6. Choudhuri G, Somani SK, Baba CS, Alexander G. Autoimmune hepatitis in India: profile of an uncommon disease. BMC Gastroenterol 2005;5:27.
7. Johnson PJ, McFarlane IG, Alvarez F, Bianchi FB, Bianchi L, Burroughs A, et al. Meeting Report, International Autoimmune Hepatitis Group, Hepatology 1993;18:998-1005.
8. Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, et al. International Autoimmune Hepatitis Group report: Review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999;31:929-938
9. Hennes EM, Zeniya M, Czaja AJ, Parés A, Dalekos GN, Krawitt EL, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 2008;48:169-176
10. Montano Loza AJ, Czaja AJ. Current therapy for autoimmune hepatitis. Nat Clin Pract Gastroenterol Hepatol 2007;4:202-214
11. Czaja AJ. Progress in the diagnosis and treatment of autoimmune hepatitis. Minerva Med 2008;99:549-568
12. Feld JJ, Dinh H, Arenovich T, Marcus VA, Wanless IR, Heathcote EJ. Autoimmune hepatitis: Effect of symptoms and cirrhosis on natural history and outcome. Hepatology 2005;42:53-62.
13. Vogel A, Heinrich E, Bahr MJ, Rifai K, Flemming P, Melter M, et al. Longterm outcome of liver transplantation for autoimmune hepatitis. Clin Transplant 2004;18:62-69
14. Bashawri LA, Fawaz NA, Ahmed MS. Prevalence of seromarkers of HBV and HCV among blood donord in eastern Saudi Arabia. Clinical lab Hematol 2004;26:225-228
15. Hazmi EL. Prevalence of HBV, HCV, HIV-I,II infections among blood donors in a teaching hospital in the central region of Saudi Arabia. Saudi Med J 2004;25:26-33.
16. Abdo AA. Clinical presentation, response to therapy, and predictors of fibrosis in patients with autoimmune hepatitis in Saudi Arabia. Saudi J Gastroenterol. 2006;12:73-76
17. Khalaf H, Mourad W, El-Sheikh Y, Abdo A, Helmy A, Medhat Y, et al. Liver transplantation for autoimmune hepatitis: A single-center experience. Transplant Proc 2007;39:1166-1170 (Pubitemid 46764831)
18. Ferrari R, Pappas G, Agostinelli D, Muratori P, Muratori L, Lenzi M, et al. Type 1 autoimmune hepatitis: Patterns of clinical presentation and differential diagnosis of the acute type. Q J Med 2004;97:407-412
19. Czaja A, Freese D. Diagnosis and treatment of autoimmune hepatitis. Hepatology 2002;36:479-497
20. Huang H, Huang Y, Wu J, Tsay S, Huo T, Wang Y, et al. Characteristics of autoimmune hepatitis in Taiwan: The 11 years' experiences of a medical center. Zhonghua Yi Xue Za Zhi (Taipei) 2002;65:563-569
21. Czaja AJ. Behavior and significance of autoantibodies in type 1 autoimmune hepatitis. J Hepatol 1999;30:394-401.
22. Ichai P, Duclos-Vallée JC, Guettier C, Hamida SB, Antonini T, Delvart V, et al. Usefulness of corticosteroids for the treatment of severe and fulminant forms of autoimmune hepatitis. Liver Transpl 2007;13:996-1003.
23. Hennes EM, Oo YH, Schramm C, Denzer U, Buggisch P, Wiegard C, et al. Mycophenolate mofetil as second line therapy in autoimmune hepatitis. Am J Gastroenterol 2008;103:3063-3070
24. Verma S, Torbenson M, Thuluvath PJ. The impact of ethnicity on the natural history of autoimmune hepatitis. Hepatology 2007;46:1828-1835